ITT-5 Mechanisms of Spermatogenesis
Condition: Gonadotropin DeficiencyInterventions: Drug: Testosterone 1% Gel; Drug: Acyline; Drug: Dutasteride; Drug: Ketoconazole; Drug: HCG; Drug: placebo dutasteride; Drug: placebo ketoconazoleSponsor: University of WashingtonNot yet recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2014 Category: Research Source Type: clinical trials
Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma
Conditions: Recurrent Neuroblastoma; NeuroblastomaInterventions: Drug: Fenretinide Lym-X-Sorb Oral Powder; Drug: KetoconazoleSponsor: South Plains Oncology ConsortiumAvailable - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2014 Category: Research Source Type: clinical trials
A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199
Condition: Non-Hodgkin's LymphomaInterventions: Drug: ABT-199; Drug: KetoconazoleSponsors: AbbVie; Genentech, Inc.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2013 Category: Research Source Type: clinical trials
A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma
Condition: Malignant Melanoma, NeoplasmsInterventions: Drug: ketoconazole; Drug: vemurafenibSponsor: Hoffmann-La RocheWithdrawn - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2013 Category: Research Source Type: clinical trials
A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma
Condition: Malignant Melanoma, NeoplasmsInterventions: Drug: ketoconazole; Drug: vemurafenibSponsor: Hoffmann-La RocheWithdrawn - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2013 Category: Research Source Type: clinical trials